A comparison of two commercial recombinant vaccines for hepatitis B in adolescents
- 1 November 2000
- Vol. 19 (7-8) , 937-942
- https://doi.org/10.1016/s0264-410x(00)00217-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000
- Over a decade of experience with a yeast recombinant hepatitis B vaccineVaccine, 1999
- Long–Term Response to Hepatitis B Vaccination and Response to Booster in Children Born to Mothers With Hepatitis B E AntigenHepatology, 1999
- Status of hepatitis B immunization programmes in 1998Vaccine, 1998
- Prevention of Primary Liver Cancer by ImmunizationNew England Journal of Medicine, 1997
- Antigen localisation regulates immune responses in a dose‐ and time‐dependent fashion: a geographical view of immune reactivityImmunological Reviews, 1997
- Global status of hepatitis B immunisationThe Lancet, 1996
- Assessment of a universal, school-based hepatitis B vaccination programJAMA, 1995
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988